Related Experiment Videos
Residual tumor (R) classification and prognosis
1Department of Surgery, University of Erlangen, Germany.
Seminars in Surgical Oncology
|January 1, 1994
Summary
Residual tumor (R) classification (R0, R1, R2) after cancer treatment is crucial for planning further therapy and predicting patient prognosis. R classification significantly impacts long-term outcomes, independent of cancer stage.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Treatment
Background:
- The residual tumor (R) classification system (R0, R1, R2) describes tumor status post-treatment.
- Residual tumor can be present at the primary site, regional lymph nodes, or distant sites.
Purpose of the Study:
- To highlight the importance of R classification in treatment planning and prognosis.
- To emphasize the prognostic significance of R classification across various cancer types.
Main Methods:
- Review of the R classification system and its implications.
- Analysis of prognostic data related to R classification in specific cancers.
Main Results:
- R classification is a critical factor influencing treatment decisions and predicting patient outcomes.
- R0 (no residual tumor) is associated with an acceptable long-term prognosis.
- Prognostic differences between R0 and R1/R2 classifications are not solely explained by cancer stage.
Conclusions:
- The R classification is a powerful prognostic indicator in oncology.
- Accurate R classification is essential for effective cancer management and patient counseling.
- The prognostic impact of residual tumor status is evident in diverse malignancies including lung, esophageal, gastric, pancreatic, and colorectal cancers, as well as metastases.